- Home
- RIGL vs LEGH Comparison
RIGL vs LEGH Comparison
Compare RIGL & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- LEGH
- Stock Information
- Founded
- RIGL 1996
- LEGH 2005
- Country
- RIGL United States
- LEGH United States
- Employees
- RIGL N/A
- LEGH N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- LEGH Homebuilding
- Sector
- RIGL Health Care
- LEGH Consumer Discretionary
- Exchange
- RIGL Nasdaq
- LEGH Nasdaq
- Market Cap
- RIGL 537.6M
- LEGH 538.2M
- IPO Year
- RIGL 2000
- LEGH 2018
- Fundamental
- Price
- RIGL $41.76
- LEGH $19.46
- Analyst Decision
- RIGL Buy
- LEGH Buy
- Analyst Count
- RIGL 6
- LEGH 3
- Target Price
- RIGL $39.83
- LEGH $25.00
- AVG Volume (30 Days)
- RIGL 652.5K
- LEGH 108.8K
- Earning Date
- RIGL 11-04-2025
- LEGH 11-07-2025
- Dividend Yield
- RIGL N/A
- LEGH N/A
- EPS Growth
- RIGL 2698.26
- LEGH N/A
- EPS
- RIGL 6.20
- LEGH 1.95
- Revenue
- RIGL $282,076,000.00
- LEGH $180,497,000.00
- Revenue This Year
- RIGL $59.93
- LEGH $1.51
- Revenue Next Year
- RIGL N/A
- LEGH $7.92
- P/E Ratio
- RIGL $6.77
- LEGH $10.06
- Revenue Growth
- RIGL 79.13
- LEGH 10.25
- 52 Week Low
- RIGL $14.63
- LEGH $19.38
- 52 Week High
- RIGL $43.72
- LEGH $29.45
- Technical
- Relative Strength Index (RSI)
- RIGL 69.92
- LEGH 26.34
- Support Level
- RIGL $34.00
- LEGH $19.38
- Resistance Level
- RIGL $39.56
- LEGH $20.40
- Average True Range (ATR)
- RIGL 2.35
- LEGH 0.86
- MACD
- RIGL 1.10
- LEGH -0.24
- Stochastic Oscillator
- RIGL 93.00
- LEGH 1.64
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.